SER-287

DB18204InvestigationalOrganism Based Therapies

SER-287 comprises healthy microbiome-derived Gram positive bacterial spores.

Code names
SER-287

Resolves to

Compound
UNII6GU6LU5E7R

What you can answer from here — as of April 23, 2025

2Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of SER-287, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In